Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations
Authors
Keywords
Cardiovascular outcomes, Epidemiological methods, Glucose-lowering medications, Observational studies, Review
Journal
DIABETOLOGIA
Volume 57, Issue 11, Pages 2237-2250
Publisher
Springer Nature
Online
2014-09-11
DOI
10.1007/s00125-014-3364-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative Effectiveness of Sulfonylurea and Metformin Monotherapy on Cardiovascular Events in Type 2 Diabetes Mellitus
- (2013) Christianne L. Roumie et al. ANNALS OF INTERNAL MEDICINE
- Effects of Thiazolidinediones on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus After Drug-Eluting Stent Implantation: A Retrospective Cohort Study Using the National Health Insurance Database in Taiwan
- (2012) Hsien-Tsung Yeh et al. CLINICAL THERAPEUTICS
- Effect of rosiglitazone on survival in patients with diabetes mellitus treated for coronary artery disease
- (2012) Alana Choy-Shan et al. CORONARY ARTERY DISEASE
- Metformin and the Risk of Cancer: Time-related biases in observational studies
- (2012) S. Suissa et al. DIABETES CARE
- Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer
- (2012) A. G. Renehan et al. DIABETOLOGIA
- Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence
- (2012) J. A. Johnson et al. DIABETOLOGIA
- Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETOLOGIA
- Micro- and macrovascular outcomes in Type 2 diabetic patients treated with insulin glulisine or human regular insulin: a retrospective database analysis
- (2012) Stephan Kress et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- What Next after Metformin? A Retrospective Evaluation of the Outcome of Second-Line, Glucose-Lowering Therapies in People with Type 2 Diabetes
- (2012) Christopher Ll. Morgan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The incident user design in comparative effectiveness research
- (2012) Eric S. Johnson et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system
- (2012) Jeremy A. Rassen et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A systematic review of validated methods for identifying heart failure using administrative data
- (2012) Jane S. Saczynski et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Covariate Selection in High-Dimensional Propensity Score Analyses of Treatment Effects in Small Samples
- (2011) Jeremy A. Rassen et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Incidence of Cardiovascular Events in Which 2 Thiazolidinediones Are Used as Add-on Treatments for Type 2 Diabetes Mellitus in a Taiwanese Population
- (2011) Chih-Chieh Chou et al. CLINICAL THERAPEUTICS
- Beyond the intention-to-treat in comparative effectiveness research
- (2011) Miguel A Hernán et al. Clinical Trials
- Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure
- (2011) Charlotte Andersson et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study
- (2011) Tina Ken Schramm et al. EUROPEAN HEART JOURNAL
- Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes
- (2011) Tze-Fan Chao et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study
- (2011) Henriette Thisted Horsdal et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Thiazolidinediones and the risk of incident congestive heart failure among patients with type 2 diabetes mellitus
- (2011) Kristian B. Filion et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Effect of Metformin on Mortality in Patients With Heart Failure and Type 2 Diabetes Mellitus
- (2010) Josie M.M. Evans et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention - a retrospective nationwide cohort study
- (2010) Casper H Jørgensen et al. Cardiovascular Diabetology
- Risk of Cardiovascular Events and All-Cause Mortality in Patients Treated With Thiazolidinediones in a Managed-Care Population
- (2010) Debra A. Wertz et al.
- The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: A retrospective cohort study using a US health insurance database
- (2010) Najat Ziyadeh et al. CLINICAL THERAPEUTICS
- Treatment of Type 2 Diabetes and Outcomes in Patients With Heart Failure: A Nested Case-Control Study From the U.K. General Practice Research Database
- (2010) M. R. MacDonald et al. DIABETES CARE
- Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies: A retrospective analysis of the LifeLink database
- (2010) J. H. Best et al. DIABETES CARE
- Sulphonylurea-metformin combination therapy, cardiovascular disease and all-cause mortality: the Fremantle Diabetes Study
- (2010) B. Sillars et al. DIABETES OBESITY & METABOLISM
- Thiazolidinediones and congestive heart failure in veterans with type 2 diabetes
- (2010) A. Toprani et al. DIABETES OBESITY & METABOLISM
- Diabetes therapy and cancer risk: causal effects and other plausible explanations
- (2010) S. Hernández-Díaz et al. DIABETOLOGIA
- Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study
- (2010) C. Andersson et al. DIABETOLOGIA
- Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a population-based cohort study in Italy
- (2010) Giovanni Corrao et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone
- (2010) David J. Graham et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Database Evaluation of the Effects of Long-Term Rosiglitazone Treatment on Cardiovascular Outcomes in Patients With Type 2 Diabetes
- (2010) Ronen Loebstein et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Relationship between cumulative dose of thiazolidinediones and clinical outcomes in type 2 diabetic patients with history of heart failure: a population-based cohort study in Taiwan
- (2010) Fei-Yuan Hsiao et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population
- (2010) Peter M. Wahl et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A basic study design for expedited safety signal evaluation based on electronic healthcare data
- (2010) Sebastian Schneeweiss PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis
- (2009) Kevin M. Pantalone et al. ACTA DIABETOLOGICA
- Comparison of Incidence of Acute Myocardial Infarction in Patients With Type 2 Diabetes Mellitus Following Initiation of Neutral Protamine Hagedorn Insulin Versus Insulin Glargine
- (2009) George G. Rhoads et al. AMERICAN JOURNAL OF CARDIOLOGY
- Stroke and cardiovascular morbidity and mortality associated with rosiglitazone use in elderly diabetic patients
- (2009) Alain Vanasse et al. Diabetes & Vascular Disease Research
- Insulin use and increased risk of mortality in type 2 diabetes: a cohort study
- (2009) J.-M. Gamble et al. DIABETES OBESITY & METABOLISM
- Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort study
- (2009) Mykola Khalangot et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population-based follow-up study
- (2009) Henriette T. Horsdal et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Thiazolidinediones and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus
- (2009) Fei-Yuan Hsiao et al. DRUG SAFETY
- High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data
- (2009) Sebastian Schneeweiss et al. EPIDEMIOLOGY
- Overadjustment Bias and Unnecessary Adjustment in Epidemiologic Studies
- (2009) Enrique F. Schisterman et al. EPIDEMIOLOGY
- Rosiglitazone Is Associated with Mortality in Chronic Hemodialysis Patients
- (2009) S. P.B. Ramirez et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of Second-Generation Sulfonylureas on Survival in Patients With Diabetes Mellitus After Myocardial Infarction
- (2009) Adelaide M. Arruda-Olson et al. MAYO CLINIC PROCEEDINGS
- Incidence rates of heart failure, stroke, and acute myocardial infarction among Type 2 diabetic patients using insulin glargine and other insulin
- (2009) Juhaeri Juhaeri et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis
- (2009) Zeina A. Habib et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Association Between Extent of Thiazolidinedione Exposure and Risk of Acute Myocardial Infarction
- (2009) David D Dore et al. PHARMACOTHERAPY
- Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
- (2009) Colin R. Dormuth et al. PLoS One
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
- (2009) Peter C. Austin STATISTICS IN MEDICINE
- Comparison of Cardiovascular Outcomes in Elderly Patients With Diabetes Who Initiated Rosiglitazone vs Pioglitazone Therapy
- (2008) Wolfgang C. Winkelmayer et al. ARCHIVES OF INTERNAL MEDICINE
- Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups
- (2008) Daniel H. Solomon et al. ARTHRITIS AND RHEUMATISM
- Cardiovascular events and insulin therapy: A retrospective cohort analysis
- (2008) Nicole M. Engel-Nitz et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: A matched case–control study
- (2008) Shaukat M. Sadikot et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy
- (2008) Finlay A. McAlister et al. EUROPEAN JOURNAL OF HEART FAILURE
- Coronary heart disease outcomes in patients receiving antidiabetic agents in the PharMetrics database 2000-2007
- (2008) Alexander M. Walker et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- An assessment of the effect of thiazolidinedione exposure on the risk of myocardial infarction in type 2 diabetic patients
- (2008) Carol E. Koro et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Association between serious ischemic cardiac outcomes and medications used to treat diabetes
- (2008) David J. Margolis et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Risk of acute myocardial infarction in patients treated with thiazolidinediones or other antidiabetic medications
- (2008) Karen M. Stockl et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Immortal Time Bias in Pharmacoepidemiology
- (2007) S. Suissa AMERICAN JOURNAL OF EPIDEMIOLOGY
- Insulin-sensitizing antihyperglycaemic medications are associated with better outcome in patients with diabetes undergoing cardiac stress testing
- (2007) K. Kapinya et al. INTERNAL MEDICINE JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now